Nuveen LLC Makes New Investment in Integral Ad Science Holding Corp. $IAS

Key Points

• Nuveen LLC has acquired a new stake in Integral Ad Science Holding Corp. valued at approximately $10.90 million, owning 0.83% of the company.
• Investment activity includes >95% of the stock held by institutional investors, with Vanguard Group and others increasing their stakes alongside significant changes from Dimensional Fund Advisors and Alyeska Investment Group.
• Several analysts have updated their ratings and price targets for the stock, leading to an overall consensus rating of "Moderate Buy" with a price target averaging around $13.55.

Nuveen LLC acquired a new stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,352,028 shares of the company's stock, valued at approximately $10,897,000. Nuveen LLC owned 0.83% of Integral Ad Science as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in IAS. DekaBank Deutsche Girozentrale bought a new position in Integral Ad Science in the first quarter worth approximately $42,000. State of Wyoming bought a new position in Integral Ad Science in the fourth quarter worth approximately $51,000. Alta Fox Capital Management LLC bought a new position in Integral Ad Science in the fourth quarter worth approximately $61,000. Virtu Financial LLC bought a new position in Integral Ad Science in the first quarter worth approximately $87,000. Finally, Teacher Retirement System of Texas bought a new position in Integral Ad Science in the first quarter worth approximately $96,000. 95.78% of the stock is currently owned by institutional investors.

Insider Activity at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 14,904 shares of Integral Ad Science stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total value of $123,852.24. Following the completion of the transaction, the chief executive officer directly owned 379,316 shares of the company's stock, valued at $3,152,115.96. This trade represents a 3.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Over the last three months, insiders have sold 35,073 shares of company stock valued at $289,641. Company insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on IAS shares. Raymond James Financial decreased their price target on shares of Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a research report on Friday, August 8th. Wall Street Zen upgraded shares of Integral Ad Science from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Stifel Nicolaus increased their price target on shares of Integral Ad Science from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Tuesday, July 22nd. Finally, Barclays raised their price objective on shares of Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a research report on Friday, August 8th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $13.55.

Integral Ad Science Trading Up 1.1%

IAS traded up $0.10 during trading on Thursday, hitting $9.14. 785,122 shares of the company traded hands, compared to its average volume of 883,657. The company has a market cap of $1.52 billion, a PE ratio of 26.88, a P/E/G ratio of 1.31 and a beta of 1.57. The stock's 50-day simple moving average is $8.44 and its two-hundred day simple moving average is $8.39. Integral Ad Science Holding Corp. has a 1 year low of $6.26 and a 1 year high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. The business had revenue of $149.20 million during the quarter, compared to analysts' expectations of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.